Cancer induced cachexia, a gross loss of skeletal muscle with or without adipose tissue wasting, remains a clinical impasse resulting in poor prognosis and Quality of Life (QoL). It is characterized by an inflammation driven anorexia and aberrant energy and protein balance. Indubitably, nutritional rehabilitation is required to address various daunting challenges of this multifactorial syndrome. Esperer Onco Nutrition has come up with an optimal clinical nutrition formulation with promising anti-cachexia effects. Towards validating the efficacy and ensuring the safety of EON Therapy (Es-Invigour plus Es-Fortitude-Protect) under clinical settings, a phase IV post marketing surveillance (PMS) study with 63 patients from various hospitals across India was undertaken. This multi-nutrient and multi-targeted nutritional intervention, being concurrent with mainstream therapy, demonstrated potential to ameliorate the cachectic condition which was measured by body weight of the volunteers at each visit. Biochemical parameters improved or remained same. Overall QoL assessment was performed by using ECOG Scale and Malnutrition Screening Tool (MST) which showed significant improvement in physical wellness and nutritional status of the volunteers. No adverse effect was observed during the entire period. These observations reinforce the need of research based nutritional intervention for clinical use in cachectic cancer patients.
KeywordsCancerCachexiaNutritional InterventionEON TherapyQuality of Life
Fearon, K., Arends, J. and Baracos, V. (2013) Understanding the Mechanisms and Treatment Options in Cancer Cachexia. Nature Reviews Clinical Oncology, 10, 90-99. https://doi.org/10.1038/nrclinonc.2012.209
Tisdale, M.J. (2002) Cachexia in Cancer Patients. Nature Reviews Cancer, 2, 862-871. https://doi.org/10.1038/nrc927
Penna, F., Baccino, F.M. and Costelli, P. (2014) Coming back: Autophagy in Cachexia. Current Opinion in Clinical Nutrition & Metabolic Care, 17, 241-246. https://doi.org/10.1097/MCO.0000000000000048
Purcell, S.A., Elliott, S.A., Baracos, V.E., Chu, Q.S.C. and Prado, C.M. (2016) Key Determinants of Energy Expenditure in Cancer and Implications for Clinical Practice. European Journal of Clinical Nutrition, 70, 1230-1238. https://doi.org/10.1038/ejcn.2016.96
Vazeille, C., Jouinot, A., Durand, J.P., Neveux, N., Boudou-Rouquette, P., Huillard, O., et al. (2017) Relation between Hypermetabolism, Cachexia, and Survival in Cancer Patients: A Prospective Study in 390 Cancer Patients before Initiation of Anticancer Therapy. American Journal of Clinical Nutrition, 105, 1139-1147. https://doi.org/10.3945/ajcn.116.140434
Fearon, K., Strasser, F., Anker, S.D., Bosaeus, I., Bruera, E., Fainsinger, R.L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., Davis, M., Muscaritoli, M., Ottery, F., Radbruch, L., Ravasco, P., Walsh, D., Wilcock, A., Kaasa, S. and Baracos, V.E. (2011) Definition and Classification of Cancer Cachexia: An International Consensus. The Lancet Oncology, 12, 489-495. https://doi.org/10.1016/S1470-2045(10)70218-7
Anker, M.S., Holcomb, R., Muscaritoli, M., von Haehling, S., Haverkamp, W., Jatoi, A., et al. (2019) Orphan Disease Status of Cancer Cachexia in the USA and in the European Union: A Systematic Review. Journal of Cachexia, Sarcopenia and Muscle, 10, 22-34. https://doi.org/10.1002/jcsm.12402
von Meyenfeldt, M. (2005) Cancer-Associated Malnutrition: An Introduction. European Journal of Oncology Nursing, 9, S35-S38. https://doi.org/10.1016/j.ejon.2005.09.001
Schmitt, T.L., Martignoni, M.E., Bachmann, J., et al. (2007) Activity of the Akt-Dependent Anabolic and Catabolic Pathways in Muscle and Liver Samples in Cancer-Related Cachexia. Journal of Molecular Medicine, 85, 647-654. https://doi.org/10.1007/s00109-007-0177-2
Johnen, H., Lin, S., Kuffner, T., Brown, D.A., Tsai, V.W., Bauskin, A.R., et al. (2007) Tumor Induced Anorexia and Weight Loss Are Mediated by the TGF-Beta Superfamily Cytokine MIC-1. Nature Medicine, 13, 1333-1340. https://doi.org/10.1038/nm1677
Burfeind, K.G., Michaelis, K.A. and Marks, D.L. (2016) The Central Role of Hypothalamic Inflammation in the Acute Illness Response and Cachexia. Seminars in Cell and Developmental Biology, 54, 42-52. https://doi.org/10.1016/j.semcdb.2015.10.038
Grober, U., Holzhauer, P., Kisters, K., Holick, M.F. and Adamietz, I.A. (2016) Micronutrients in Oncological Intervention. Nutrients, 8, Article No. 163. https://doi.org/10.3390/nu8030163
van de Worp, W.R.P.H., Schols, A.M.W.J., Theys, J., van Helvoort. A. and Langen, R.C.J. (2020) Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives from Experimental Models. Frontiers in Nutrition, 7, Article ID: 601329. https://doi.org/10.3389/fnut.2020.601329
Azam, F., Latif, M.F., Farooq, A., Tirmazy, S.H., AlShahrani, S., Bashir, S. and Bukhari, N. (2019) Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Reports in Oncology, 12, 728-736. https://doi.org/10.1159/000503095
Di Bella, A., Croisier, E., Blake, C., Pelecanos, A., Bauer, J. and Brown, T. (2020) Assessing the Concurrent Validity and Interrater Reliability of Patient-Led Screening Using the Malnutrition Screening Tool in the Ambulatory Cancer Care Outpatient Setting. Journal of the Academy of Nutrition and Dietetics, 120, 1210-1215. https://doi.org/10.1016/j.jand.2019.10.015
Fearon, K.C., Glass, D.J. and Guttridge, D.C. (2012) Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways. Cell Metabolism, 16, 153-166. https://doi.org/10.1016/j.cmet.2012.06.011
Johns, N., Stephens, N.A. and Fearon, K.C. (2013) Muscle Wasting in Cancer. The International Journal of Biochemistry and Cell Biology, 45, 2215-2229. https://doi.org/10.1016/j.biocel.2013.05.032
Fearon, K.C. and Baracos, V.E. (2010) Cachexia in Pancreatic Cancer: New Treatment Options and Measures of Success. HPB (Oxford), 12, 323-324. https://doi.org/10.1111/j.1477-2574.2010.00178.x
Vaughan, V.C., Martin, P. and Lewandowski, P.A. (2013) Cancer Cachexia: Impact, Mechanisms and Emerging Treatments. Journal of Cachexia, Sarcopenia and Muscle, 4, 95-109. https://doi.org/10.1007/s13539-012-0087-1
Argiles, J.M., Busquets, S., Stemmler, B. and Lopez-Soriano, F.J. (2014) Cancer Cachexia: Understanding the Molecular Basis. Nature Reviews Cancer, 14, 754-762. https://doi.org/10.1038/nrc3829
Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. https://doi.org/10.1126/science.1160809
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867. https://doi.org/10.1038/nature01322
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y. and Li, Y. (2021) Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention. Signal Transduction and Targeted Therapy, 6, 263. https://doi.org/10.1038/s41392-021-00658-5
Greten, F.R. and Grivennikov, S.I. (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51, 27-41. https://doi.org/10.1016/j.immuni.2019.06.025
Hanahan, D. and Weinberg R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
Straub, R.H. (2012) Evolutionary Medicine and Chronic Inflammatory State—Known and New Concepts in Pathophysiology. Journal of Molecular Medicine, 90, 523-534. https://doi.org/10.1007/s00109-012-0861-8
Winter, A., MacAdams, J. and Chevalier, S. (2012) Normal Protein Anabolic Response to Hyperaminoacidemia in Insulin-Resistant Patients with Lung Cancer Cachexia. Clinical Nutrition, 31, 765-773. https://doi.org/10.1016/j.clnu.2012.05.003
Straub, R.H., Cutolo, M., Buttgereit, F. and Pongratz, G. (2010) Energy Regulation and Neuroendocrine-Immune Control in Chronic Inflammatory Diseases. Journal of Internal Medicine, 267, 543-560. https://doi.org/10.1111/j.1365-2796.2010.02218.x
Honors, M.A. and Kinzig, K.P. (2012) The Role of Insulin Resistance in the Development of Muscle Wasting during CANCER CACHEXIA. Journal of Cachexia, Sarcopenia and Muscle, 3, 5-11. https://doi.org/10.1007/s13539-011-0051-5
Aoyagi, T., Terracina, K.P., Raza, A., Matsubara, H. and Takabe, K. (2015) Cancer Cachexia, Mechanism and Treatment. World J Gastrointestinal Oncology, 7, 17-29. https://doi.org/10.4251/wjgo.v7.i4.17
Cohen, S., Nathan, J.A. and Goldberg, A.L. (2015) Muscle Wasting in Disease: Molecular Mechanisms and Promising Therapies. Nature Reviews Drug Discovery, 14, 58-74. https://doi.org/10.1038/nrd4467
Porporato, P.E. (2016) Understanding Cachexia as a Cancer Metabolism Syndrome. Oncogenesis, 5, e200. https://doi.org/10.1038/oncsis.2016.3
Prado, C.M., Purcell, S.A. and Laviano, A. (2020) Nutrition Interventions to Treat Low Muscle Mass in Cancer. Journal of Cachexia, Sarcopenia and Muscle, 11, 366-380. https://doi.org/10.1002/jcsm.12525
Arends, J. (2018) Struggling with Nutrition in Patients with Advanced Cancer: Nutrition and Nourishment—Focusing on Metabolism and Supportive Care. Annals of Oncology, 29, ii27-ii34. https://doi.org/10.1093/annonc/mdy093
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., Krznaric, Z., Laird, B., Larsson, M., Laviano, A., Mühlebach, S., Muscaritoli, M., Oldervoll, L., Ravasco, P., Solheim, T., Strasser, F., de van der Schueren, M. and Preiser, J.C. (2017) ESPEN Guidelines on Nutrition in Cancer Patients. Clinical Nutrition, 36, 11-48. https://doi.org/10.1016/j.clnu.2016.07.015
Surendran, S., Devi, R., Chattopadhyay, R., Mukherjee, A. and Charde, S. (2022) Managing Cachexia and Improving Quality of Life in Cancer Patients Using Novel Nutritional Supplements: A PAN India Study. Journal of Cancer Therapy, 13, 88-104. https://doi.org/10.4236/jct.2022.132007
Giordano, A. and Tommonaro, G. (2019) Curcumin and Cancer. Nutrients, 11, Article No. 2376. https://doi.org/10.3390/nu11102376
Kawata, A., Murakami, Y., Suzuki, S. and Fujisawa, S. (2018) Anti-Inflammatory Activity of β-Carotene, Lycopene and Tri-n-Butylborane, a Scavenger of Reactive Oxygen Species. In Vivo, 32, 255-264. https://doi.org/10.21873/invivo.11232
Lee, J.H., Park, E., Jin, H.J., Lee, Y., Choi, S.J., Lee, G.W., Chang, P.S. and Paik, H.D. (2017) Anti-Inflammatory and Anti-Genotoxic Activity of Branched Chain Amino Acids (BCAA) in Lipopolysaccharide (LPS) Stimulated RAW 264.7 Macrophages. Food Science and Biotechnology, 26, 1371-1377. https://doi.org/10.1007/s10068-017-0165-4
Costello, L.C. and Franklin, R.B. (2012) Cytotoxic/Tumor Suppressor Role of Zinc for the Treatment of Cancer: An Enigma and an Opportunity. Expert Review of Anticancer Therapy, 12, 121-128. https://doi.org/10.1586/era.11.190
Cheng, J. and Ouwehand, A.C. (2020) Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. Nutrients, 12, Article No. 132. https://doi.org/10.3390/nu12010132